Piramal Pharma Share Price
Know More₹226.75 5.50 (2.49%)
21-Mar-2025₹226.83 5.54 (2.50%)
21-Mar-2025BSE : 543635
NSE : PPLPHARMA
Sector : Health care
ISIN Code : INE0DK501011
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 21-Mar-2025
| Market Cap (₹ Cr) | 30,061 |
Traded Value (₹ Cr) | 12.73 |
Volume (Shares) | 5,61,266 |
Face Value (₹) | 10 |
52-Week High (₹) | 307.85 |
52-Week High Date | 06-Nov-2024 |
52-Week Low (₹) | 117.30 |
52-Week Low Date | 26-Mar-2024 |
All Time High (₹) | 307.85 |
All Time High Date | 06-Nov-2024 |
All Time Low (₹) | 61.65 |
All Time Low Date | 28-Mar-2023 |
Piramal Pharma Ltd
Piramal Pharma Ltd News
Piramal Pharma Announcement
Piramal Pharma Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 30,072 |
| EPS - TTM (₹) [C] | 0.40 |
| P/E Ratio (X) [C] | 567.08 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 1.10 |
| Latest Dividend Date | 12-Jul-2024 |
| Dividend Yield (%) | 0.05 |
| Book Value Share (₹) [C] | 59.66 |
| P/B Ratio (₹) [C] | 3.80 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Canara Robeco Equity Hybrid Fund (IDCW-M) | 63.58 | 31,50,000 | 0.64 |
| Canara Robeco Equity Hybrid Fund (G) | 63.58 | 31,50,000 | 0.64 |
| Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) | 63.58 | 31,50,000 | 0.64 |
| Canara Robeco Equity Hybrid Fund - Direct (G) | 63.58 | 31,50,000 | 0.64 |
| Canara Robeco Balanced Advantage Fund - Reg (G) | 8.78 | 4,35,000 | 0.63 |
| Canara Robeco Balanced Advantage Fund - Reg (IDCW) | 8.78 | 4,35,000 | 0.63 |
| Canara Robeco Balanced Advantage Fund - Dir (G) | 8.78 | 4,35,000 | 0.63 |
| Canara Robeco Balanced Advantage Fund - Dir (IDCW) | 8.78 | 4,35,000 | 0.63 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 223.01 233.51 |
| Week Low/High (₹) | 199.60 234.00 |
| Month Low/High (₹) | 184.29 234.00 |
| Year Low/High (₹) | 118.25 308.00 |
| All time Low/High (₹) | 61.65 308.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 12.35% | -17.29% | 4.17% | 4.26% |
| 1 Month | 8.74% | -20.14% | 2.12% | 2.43% |
| 3 Month | -10.20% | -33.80% | -1.46% | -1.01% |
| 6 Month | 3.48% | -23.72% | -9.04% | -9.46% |
| 1 Year | 83.45% | 35.18% | 5.87% | 6.08% |
| 3 Year | - | - | 34.23% | 36.41% |
Company Info
Company Information
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Non Executive Director : Neeraj Bharadwaj
Independent Director : Jairaj Purandare
Independent Director : S Rama Dorai
Independent Director : Peter Stevenson
Independent Director : Sridhar Gorthi
Independent Director : Vibha Paul Rishi
Executive Director & CFO : Vivek Valsaraj
Company Sec. & Compli. Officer : Tanya D'Costa
Additional Director : Nathalie Leitch
Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000
FAQs about Piramal Pharma Ltd
1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 226.75 at close on 21st Mar 2025. Piramal Pharma Ltd share price was up by 2.49% over the previous closing price of Rs 221.25. Piramal Pharma Ltd share price trend:
- Last 1 Month: Piramal Pharma Ltd share price moved up by 8.74% on BSE.
- Last 3 Months: Piramal Pharma Ltd share price moved down by 10.20% on BSE.
- Last 12 Months: Piramal Pharma Ltd share price moved up by 83.45% on BSE.
2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 567.08
- Price to book value ratio is 3.80
- Dividend yield of 0.05
- The EPS (trailing 12 months) of the Piramal Pharma Ltd stock is Rs 0.40
3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 30,061 crore.
4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 307.85 and 52-week low share price is Rs 117.30.
5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a profit of Rs 118.80 crore on a total income of Rs 1,273.02 crore for the quarter ended 2024. For the year ended Dec 2024, Piramal Pharma Ltd had posted a profit of Rs 3.68 crore on a total income of Rs 2,233.40 crore.
6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Ajanta Pharma, Laurus Labs, Suven Pharma, Piramal Pharma, Gland Pharma, J B Chemicals &, Wockhardt.
7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows:
- Promoter holding in Piramal Pharma Ltd has gone down to 34.95 per cent as of Dec 2024 from 35.02 per cent as of Mar 2024.
